Read more
12:44 AM · 1 May 2026

Apple earnings beat Wall Street estimates 🚨 iPhone sales below expectations

Apple (AAPL.US) reported its latest quarterly results, but the market reaction has been muted — shares barely moved in after-hours trading. Overall, the report looks solid. Most importantly, the company’s high-margin services segment clearly beat expectations, while iPhone demand was the only slight disappointment on the product side. Sales in China came in stronger than expected.

  • Revenue: $111.18B vs $109.66B expected → beat
  • EPS: $2.01 vs $1.95 expected → beat
  • Gross margin: 49.27% vs 48.38% expected

Earnings by business segments

  • iPhone: $56.99B vs $57.21B expected → slight miss
  • Services: $30.98B vs $30.39B expected → beat
  • Mac: $8.40B vs $8.02B expected → beat (growth supported in part by MacBook Neo)
  • iPad: $6.91B vs $6.66B expected → beat
  • Wearables: $7.90B vs $7.70B expected → beat
  • Greater China: $20.50B vs $19.45B expected → beat
  • Americas rev. $45.09B, vs $45.82B expected → miss
  • Total oper expenses $18.90B, vs $18.47B expected --> miss

Tim Cook on iPhone: “Demand was off the charts, but we’re currently facing some constraints in the supply chain (...) Chip shortages weighed on overall sales."

Additionally

  • $100B share buyback authorized
  • Dividend: $0.27 per share

Apple stock (H1 timeframe)

During Thursday’s session, the stock pulled back toward support from the 50-period exponential moving average on the hourly chart.

Source: xStation5

30 April 2026, 6:41 PM

🗽S&P 500 companies with the record net margin since 2009 - FactSet data

30 April 2026, 5:04 PM

Market Wrap: UK100 skyrockets after BoE 🇬🇧 🚀 Euphoric gain as ECB Lagarde speaks 🇪🇺 📈

30 April 2026, 4:34 PM

Apple Q2 2026: stable results or the beginning of a new growth cycle?

30 April 2026, 9:55 AM

Morning Wrap: Record-breaking Big Tech results driven by AI, Fed delivers no surprises

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.